Treatment with immune checkpoint inhibitors after EGFR-TKIs in EGFR-mutated lung cancer.
Ito T, Nagashima H, Akiyama M, Utsumi Y, Sato H, Chiba S, Sugai M, Ube K, Mori Y, Watanabe K, Fukuhara T, Maemondo M.
Ito T, et al. Among authors: chiba s.
Thorac Cancer. 2022 Feb;13(3):386-393. doi: 10.1111/1759-7714.14267. Epub 2021 Dec 13.
Thorac Cancer. 2022.
PMID: 34904383
Free PMC article.